111

An early flu season, a new variant and poor takeup of vaccines leave the already vulnerable health service in a dangerous positionProf Devi Sridhar is chair of global public health at the University of EdinburghYou might be feeling stressed out seeing the headlines about “super flu” and comparing th…
109

In just a couple of weeks, we’ll be bidding farewell to 2025. And what a year it has been! Artificial intelligence is being incorporated into more aspects of our lives, weight-loss drugs have expanded in scope, and there have been some real “omg” biotech stories from the fields of gene therapy, IVF,…
440

Announcement after proposed sale falls through prompts backlash and union says more than 200 jobs at riskA Reform UK-led council plan to shut eight of its residential care homes has been condemned as “a betrayal of local people”.Days before Christmas, Derbyshire county council announced that the ho…
221

Novo Nordisk A/S won approval to sell a pill version of its obesity shot Wegovy in the US. Novo will start selling the pill, the first of the blockbuster GLP-1 class, in the US in early January. It is approved to help people lose weight or maintain previous weight loss over the long term. Bloomberg’…
332

Analysis finds those from most deprived backgrounds almost twice as likely to be admitted to hospital for respiratory conditionsPeople from the poorest backgrounds in England with serious lung conditions are more likely to be admitted to hospital for emergency care than their more affluent counterpa…
231

Scientists are beginning to understand that ageing is not simply a linear process and we age, according to recent research, in three accelerated bursts: at about 40, 60 and 80 years old. In this episode from July, Ian Sample talks to Stanford University’s Prof Michael Snyder, who explains what the d…
111

The Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's blockbuster weight-loss drug Wegovy that the company said will be available early in the new year. Why it matters: It's the first oral GLP-1 drug approved for weight loss and could provide a more convenient an…